LLMpediaThe first transparent, open encyclopedia generated by LLMs

Groupe Français d'Oncologie Pédiatrique

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 39 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted39
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Groupe Français d'Oncologie Pédiatrique
NameGroupe Français d'Oncologie Pédiatrique

Groupe Français d'Oncologie Pédiatrique is a French cooperative network of pediatric oncology centers, university hospitals, research institutes, and clinical investigators that coordinates care, research, and training for childhood cancer across France. The group interacts with international consortia, university departments, national agencies, and philanthropic organizations to harmonize protocols, advance translational research, and improve outcomes in pediatric hematology‑oncology. It collaborates with hospitals, institutes, and agencies to implement multicenter clinical trials, guidelines, and educational programs.

History

The origins trace to post‑war developments in pediatric oncology at institutions such as Institut Curie, Hôpital Robert-Debré, and Hôpital Necker-Enfants Malades where clinicians and researchers from Université Paris Cité, Sorbonne University, and regional university hospitals established cooperative networks. Influences included international organizations like St. Jude Children's Research Hospital, Children's Oncology Group, and European Society for Paediatric Oncology which shaped multicenter trial models adopted by French investigators. National health agencies such as Haute Autorité de Santé and research funders including Agence nationale de la recherche and foundations like Fondation ARC and Fondation pour la Recherche Médicale supported early registries and protocol harmonization. Over ensuing decades, alliances with biotechnology firms, academic laboratories at INSERM, CNRS, and university hospital groups consolidated infrastructure for centralized pathology review, biobanking, and data coordination.

Organization and Membership

Membership comprises pediatric oncologists, hematologists, surgeons, radiotherapists, pathologists, and basic scientists from centers including Centre Léon Bérard, Gustave Roussy, CHU de Bordeaux, CHU de Lyon, and regional university hospitals affiliated with Université de Strasbourg, Université de Lille, Université de Montpellier, and Université de Nantes. Governance structures mirror cooperative groups such as European Organisation for Research and Treatment of Cancer with steering committees, scientific advisory boards, and working groups for solid tumors, leukemias, brain tumors, and rare pediatric neoplasms. The group interfaces with regulatory and reimbursement bodies including Ministry of Health (France) and Haute Autorité de Santé while collaborating with patient advocacy organizations like Ligue Nationale contre le Cancer and charities including Téléthon (AFM).

Clinical Activities and Research

Clinical activities encompass multidisciplinary tumor boards, centralized pathology and radiology review, and integrated care pathways involving institutions like Hôpital Sainte‑Justine partners and pediatric surgery units at major teaching hospitals. Research programs span translational efforts linking laboratories at INSERM and Institut Pasteur to clinical trials, molecular diagnostics, and precision medicine initiatives informed by consortia such as International Society of Paediatric Oncology and European Genome-phenome Archive projects. Investigations include molecular characterization of leukemias, medulloblastoma, neuroblastoma, and sarcomas using technologies developed at CEA and university core facilities, with biobanks coordinated with national networks and registries similar to those at Institut Curie.

Treatment Protocols and Guidelines

The group develops standardized treatment protocols and evidence‑based guidelines for childhood cancers, modeled on frameworks used by Children's Oncology Group and St. Jude Children's Research Hospital, and aligned with recommendations from Haute Autorité de Santé. Protocols cover acute lymphoblastic leukemia, acute myeloid leukemia, central nervous system tumors, neuroblastoma, Wilms tumor, rhabdomyosarcoma, and bone sarcomas, integrating input from pediatric surgery teams at Hôpital Cochin, radiotherapy expertise at Gustave Roussy, and supportive care guidelines referencing practice at Centre Hospitalier Universitaire de Toulouse. Guidelines address chemotherapy regimens, surgical strategies, radiotherapy planning, and survivorship care coordinated with rehabilitation centers and specialty clinics at university hospitals.

Clinical Trials and Collaborations

The group conducts and coordinates multicenter phase I–III trials in collaboration with international partners including European Society for Paediatric Oncology, Children's Oncology Group, and pharmaceutical companies, and engages with regulatory agencies such as Agence nationale de sécurité du médicament et des produits de santé. Trial activity includes novel targeted therapies, immunotherapy studies, and protocolized chemotherapy intensification and de‑escalation strategies. Collaborative research extends to genomics consortia, translational platforms at Institut Pasteur, and cross‑border initiatives with centers at Great Ormond Street Hospital, Karolinska University Hospital, and Hospital for Sick Children (SickKids) to facilitate data sharing, centralized review, and harmonized outcome measures.

Education, Training, and Patient Support

Educational activities include continuing medical education, fellowships, and multidisciplinary workshops hosted with medical schools such as Université Paris Cité, Sorbonne University, and regional faculties; these mirror training models at Great Ormond Street Hospital and St. Jude Children's Research Hospital. The group partners with patient advocacy organizations including Ligue Nationale contre le Cancer and Association Française des Infirmières en Oncologie Pédiatrique to provide psychosocial support, survivorship programs, and transition‑of‑care services. Outreach and public engagement involve collaborations with foundations like Fondation pour la Recherche Médicale and media campaigns coordinated with national health institutions to raise awareness and support for pediatric oncology research.

Category:Medical and health organizations based in France Category:Pediatric oncology